Zhanglei Mu

Peking University People's Hospital
Beijing, Beijing, China

Dermatology and venereology attending physician

Presentation(s):

• 1920: A Phase Ib/II Randomized, Double-blind, Placebo-controlled Study of Novel anti-IL-17A Monoclonal Antibody JS005 in Patients with Moderate to Severe Psoriasis

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.